Kolijn D, Pabel S, Tian Y, Lodi M, et al. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Galpha oxidation. Cardiovasc Res 2020 May 12. pii: 5836298. doi: 10.1093.
PMID: 32396609